Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,518 | -13,402 | -7,307 | -14,881 | -11,965 |
| Depreciation Amortization | 21 | 14 | 7 | 27 | 21 |
| Accounts receivable | N/A | N/A | N/A | 7,500 | 7,500 |
| Accounts payable and accrued liabilities | -476 | -657 | 102 | 478 | -774 |
| Other Working Capital | 2,062 | 2,671 | 3,392 | 1,876 | 2,167 |
| Other Operating Activity | 4,179 | 2,773 | 978 | -5,289 | -4,828 |
| Operating Cash Flow | $-9,732 | $-8,602 | $-2,828 | $-10,289 | $-7,879 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -516 | N/A | N/A | -25 | -25 |
| Investing Cash Flow | $-516 | $N/A | $N/A | $-25 | $-25 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 11 | 11 |
| Common Stock Issued | 38 | 19 | 19 | 16,148 | 6,455 |
| Other Financing Activity | 0 | 0 | 0 | -132 | -132 |
| Financing Cash Flow | $38 | $19 | $19 | $16,027 | $6,335 |
| Beginning Cash Position | 38,340 | 38,340 | 38,340 | 32,627 | 32,627 |
| End Cash Position | 28,130 | 29,757 | 35,531 | 38,340 | 31,057 |
| Net Cash Flow | $-10,210 | $-8,582 | $-2,809 | $5,713 | $-1,569 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,732 | -8,602 | -2,828 | -10,289 | -7,879 |
| Capital Expenditure | -516 | N/A | N/A | -25 | -25 |
| Free Cash Flow | -10,248 | -8,602 | -2,828 | -10,314 | -7,904 |